Proteins Secreted by Lung Adenocarcinoma Cells -Identification of Candidate Diagnosis Markers from Culture Supernatants of Dissected Tumor Tissue-
暂无分享,去创建一个
T. Ohira | T. Hirano | H. Saji | M. Kakihana | M. Nomura | N. Ikeda | Y. Gong | G. Yamaguchi | R. Guo | Takao Kawakami
[1] E. Diamandis,et al. Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines* , 2009, Molecular & Cellular Proteomics.
[2] E. Diamandis,et al. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. , 2009, Journal of proteome research.
[3] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[4] Shinji Sato,et al. Amino Acid Sequence Database Suitable for the Protein and Proteome Analysis , 2008 .
[5] M. Páez de la Cadena,et al. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer. , 2008, Anticancer research.
[6] H. Iso,et al. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography , 2008, British Journal of Cancer.
[7] H. Antti,et al. Evaluation of 2‐D DIGE for skeletal muscle: Protocol and repeatability , 2008, Scandinavian journal of clinical and laboratory investigation.
[8] David E. Misek,et al. Identification of 14-3-3θ as an antigen that induces a humoral response in lung cancer , 2007 .
[9] Alissa K. Greenberg,et al. Biomarkers for lung cancer: clinical uses , 2007, Current opinion in pulmonary medicine.
[10] A. Jemal,et al. Reduced lung cancer deaths attributable to decreased tobacco use in Massachusetts , 2007, Cancer Causes & Control.
[11] J. Jett. Limitations of Screening for Lung Cancer with Low-Dose Spiral Computed Tomography , 2005, Clinical Cancer Research.
[12] H. Kato,et al. Clinical‐scale high‐throughput human plasma proteome analysis: Lung adenocarcinoma , 2005, Proteomics.
[13] Toshihide Nishimura,et al. Protein identification from product ion spectra of peptides validated by correlation between measured and predicted elution times in liquid chromatography/mass spectrometry , 2005, Proteomics.
[14] N. Anderson,et al. The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.
[15] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[16] M. Senko,et al. A two-dimensional quadrupole ion trap mass spectrometer , 2002, Journal of the American Society for Mass Spectrometry.
[17] W. Peters,et al. PLASMA GLUTATHIONE S-TRANSFERASE π1-1 AND α1-1 LEVELS IN PATIENTS WITH BLADDER CANCER , 2000 .
[18] H. Kato,et al. Human Tissue Distribution of TA02, Which is Homologous with a New Type of Aspartic Proteinase, Napsin A , 2000, Japanese journal of cancer research : Gann.
[19] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[20] A Charloux,et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. , 1997, International journal of epidemiology.
[21] G. Paludetti,et al. Cathepsin D concentration in primary laryngeal cancer: Correlation with clinico‐pathological parameters, EGFR status and prognosis , 1996, International journal of cancer.
[22] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[23] Tohru Takahashi,et al. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: Their heterology in form and analogy in immunohistochemical characteristics , 1996, Cancer.
[24] N. Kohno,et al. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. , 1988, Japanese journal of clinical oncology.
[25] David E. Misek,et al. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. , 2007, Cancer research.
[26] W. Peters,et al. Plasma glutathione S-transferase pi 1-1 AND alpha 1-1 levels in patients with bladder cancer. , 2000, The Journal of urology.
[27] M. Ünlü,et al. Difference gel electrophoresis. A single gel method for detecting changes in protein extracts , 1997, Electrophoresis.
[28] D. Hochstrasser,et al. Improved and simplified in‐gel sample application using reswelling of dry immobilized pH gradients , 1997, Electrophoresis.